Global Insomnia Pipeline Review, H2 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Insomnia
– Pipeline Review, H2 2018”
drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Insomnia – Pipeline Review, H2 2018, provides comprehensive information
on the therapeutics under development for Insomnia (Central Nervous
System), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest
news and press releases.

The Insomnia (Central Nervous System) pipeline guide also reviews of key
players involved in therapeutic development for Insomnia and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies/Universities/Institutes; the molecules
developed by Companies in Phase III, Phase II, Phase I, Preclinical,
Discovery and Unknown stages are 3, 9, 6, 8, 5 and 2 respectively.
Similarly, the Universities portfolio in Phase I and Preclinical stages
comprises 1 and 1 molecules, respectively.

Insomnia (Central Nervous System) pipeline guide helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision-making capabilities and helps to create effective
counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Insomnia – Overview
  3. Insomnia – Therapeutics Development
  4. Insomnia – Therapeutics Assessment
  5. Insomnia – Companies Involved in Therapeutics Development
  6. Insomnia – Drug Profiles
  7. Insomnia – Dormant Projects
  8. Insomnia – Discontinued Products
  9. Insomnia – Product Development Milestones
  10. Appendix

Companies Featured

  • Alexza Pharmaceuticals Inc
  • Eisai Co Ltd
  • Evotec AG
  • Grupo Ferrer Internacional SA
  • Heptares Therapeutics Ltd
  • Icure Pharmaceutical Inc
  • Idorsia Pharmaceutical Ltd
  • Intra-Cellular Therapies Inc
  • Johnson & Johnson
  • Leading BioSciences Inc
  • Merck & Co Inc
  • Neurim Pharmaceuticals Ltd
  • Purdue Pharma LP
  • Reviva Pharmaceuticals Inc
  • Sage Therapeutics Inc
  • Shionogi & Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Yangtze River Pharmaceutical Group

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qhbxhw/global_insomnia?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.